Difference between revisions of "Part:BBa K1061001"
Line 1: | Line 1: | ||
− | |||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K1061001 short</partinfo> | <partinfo>BBa_K1061001 short</partinfo> | ||
Line 17: | Line 16: | ||
<partinfo>BBa_K1061001 parameters</partinfo> | <partinfo>BBa_K1061001 parameters</partinfo> | ||
<!-- --> | <!-- --> | ||
+ | <h2>References:</h2> | ||
+ | <p>[1] Claude Backendorf et al,Apoptin: Therapeutic Potential of an Early Sensor of Carcinogenic Transformation,Annu. Rev. Pharmacol. Toxicol. 2008. 48:143–69 | ||
+ | <p> |
Revision as of 08:09, 25 September 2013
apoptin
Apoptin is a protein that is originally isolated from the chicken anemia virus(CAV). It has been found that expressing this gene can induce apoptosis in a broad spectrum of cancer cells but not in normal cells. Hence it is a very powerful tool in treating cancer. Fusion the TAT protein with apoptin can even achieve by-stander effect, and we try to use it in the most simple device of our project. We have successfully expressed it in Hep G2 cell lines and observe a brilliant apoptosis effect.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 172
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
References:
[1] Claude Backendorf et al,Apoptin: Therapeutic Potential of an Early Sensor of Carcinogenic Transformation,Annu. Rev. Pharmacol. Toxicol. 2008. 48:143–69 <p>